Omicron Booster Dose India
- All
- News
- Videos
-
Covid-19 In India: LF.7 and NB.1.8.1, New Covid Variants Detected; Do You Need A Booster Dose?
The JN.1 variant and its related descendants belong to the Omicron family.
-
Covovax To Get Approval As Covid Booster In 10-15 Days: Adar Poonawalla
Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works well against the Omicron variant of coronavirus.
-
Covaxin Booster Enhances Efficacy Against Delta, Omicron Variants: Study
The administration of Covaxin as a booster dose enhances vaccine effectiveness against COVID-19's Delta variant and gives protection against Omicron variants BA.1.1 and BA.2, a study by ICMR and Bharat Biotech has found.
-
Covaxin Booster Enhances Protection Against Variants Of Concern: ICMR Study
A booster dose of Covaxin administered six months after the two dose primary vaccination has shown elevated immune responses against SARS-CoV-2 variants of concern including Omicron, a study by ICMR and Bharat Biotech has found.
-
Booster Dose Of Covid Vaccine Needed To Fight Against Omicron: Study
Neutralising antibody levels waned after six months in those who were fully vaccinated against the coronavirus with Covishield, Covaxin and a mix of both with regard to Omicron variant, a study done by the National Institute of Virology indicated.
-
Covid Vaccine Booster Gives Effective Antibody Protection Against Omicron: Study
A third dose of COVID-19 vaccine increases the level of antibodies that can effectively neutralise the Omicron variant of coronavirus, according to a study published in The Lancet journal.
-
Everyone Will Get Omicron, Boosters Won't Stop It: Top Medical Expert
Stressing that Covid is "not a frightening disease anymore" as the new strain is milder and is leading to much less hospitalisation, he said that it's a disease we can deal with.
-
3rd Covaxin Dose Holds Promise: Medical Body Ahead Of Booster Dose Drive
Third dose of Covaxin holds promise, Indian Council of Medical Research said on Sunday just a day before government plans to administer 'precaution' doses of Covid vaccines to frontline, healthcare workers and senior citizens with co-morbidities.
-
Booster Dose Protects Adults Above 65 Against Omicron Infections: UK Study
A third top-up booster dose of a COVID-19 vaccine provides high levels of protection against severe disease from the Omicron variant among older adults, a latest UK study concluded on Saturday.
-
New Registration Not Needed For Covid Vaccine Booster Shot: Centre
There is no need for new registration for those taking the precautionary dose of COVID-19 vaccine and they can directly take an appointment from today or walk-in, the Union Health Ministry said.
-
Covid-19 In India: LF.7 and NB.1.8.1, New Covid Variants Detected; Do You Need A Booster Dose?
The JN.1 variant and its related descendants belong to the Omicron family.
-
Covovax To Get Approval As Covid Booster In 10-15 Days: Adar Poonawalla
Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works well against the Omicron variant of coronavirus.
-
Covaxin Booster Enhances Efficacy Against Delta, Omicron Variants: Study
The administration of Covaxin as a booster dose enhances vaccine effectiveness against COVID-19's Delta variant and gives protection against Omicron variants BA.1.1 and BA.2, a study by ICMR and Bharat Biotech has found.
-
Covaxin Booster Enhances Protection Against Variants Of Concern: ICMR Study
A booster dose of Covaxin administered six months after the two dose primary vaccination has shown elevated immune responses against SARS-CoV-2 variants of concern including Omicron, a study by ICMR and Bharat Biotech has found.
-
Booster Dose Of Covid Vaccine Needed To Fight Against Omicron: Study
Neutralising antibody levels waned after six months in those who were fully vaccinated against the coronavirus with Covishield, Covaxin and a mix of both with regard to Omicron variant, a study done by the National Institute of Virology indicated.
-
Covid Vaccine Booster Gives Effective Antibody Protection Against Omicron: Study
A third dose of COVID-19 vaccine increases the level of antibodies that can effectively neutralise the Omicron variant of coronavirus, according to a study published in The Lancet journal.
-
Everyone Will Get Omicron, Boosters Won't Stop It: Top Medical Expert
Stressing that Covid is "not a frightening disease anymore" as the new strain is milder and is leading to much less hospitalisation, he said that it's a disease we can deal with.
-
3rd Covaxin Dose Holds Promise: Medical Body Ahead Of Booster Dose Drive
Third dose of Covaxin holds promise, Indian Council of Medical Research said on Sunday just a day before government plans to administer 'precaution' doses of Covid vaccines to frontline, healthcare workers and senior citizens with co-morbidities.
-
Booster Dose Protects Adults Above 65 Against Omicron Infections: UK Study
A third top-up booster dose of a COVID-19 vaccine provides high levels of protection against severe disease from the Omicron variant among older adults, a latest UK study concluded on Saturday.
-
New Registration Not Needed For Covid Vaccine Booster Shot: Centre
There is no need for new registration for those taking the precautionary dose of COVID-19 vaccine and they can directly take an appointment from today or walk-in, the Union Health Ministry said.
